Anti-platelet agents in pediatric cardiac practice
暂无分享，去创建一个
Pediatric patients with a variety of congenital and acquired cardiac conditions receive antithrombotic therapy. Many of the indications are empirical, and have either not been proven in controlled studies or are extrapolated from adult studies. This article reviews the current available literature regarding the use of anti-platelet drugs in the pediatric cardiac population.
[1] F. Kirkham,et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.
[2] K. Tripathi. Drugs Affecting Coagulation, Bleeding and Thrombosis , 2008 .
[3] K. Mann,et al. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. , 2007, Blood.
[4] Shih-Ming Huang,et al. Treatment of Acute Kawasaki Disease: Aspirin’s Role in the Febrile Stage Revisited , 2004, Pediatrics.